Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Clinical Sarcoma Research
|
January 13, 2017
Radiotherapy in the management of gist: state of the art and new potential scenarios
L Gatto, M Nannini, M Saponara, et al.
International Journal of Oncology
|
August 13, 2008
Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases
M A Pantaleo, M Nannini, E Lopci, et al.
Journal of Endocrinological Investigation
|
February 17, 2020
Radiologically defined lipid-poor adrenal adenomas: histopathological characteristics
A De Leo, C Mosconi, G Zavatta, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 12, 2018
Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments
S Tavolari, M Deserti, F Vasuri, et al.
Diseases of the Colon and Rectum
|
November 15, 2006
Impact of surgery on the development of duodenal cancer in patients with familial adenomatous polyposis
G Biasco, E Nobili, C Calabrese, et al.
Journal of Chemotherapy (Florence, Italy)
|
July 9, 2008
The role of cetuximab in pre-treated refractory patients with metastatic colorectal cancer: outcome study in clinical practice
G Lelli, S Cataldo, I Carandina, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 8, 2014
Activity of sunitinib in extraskeletal myxoid chondrosarcoma
S Stacchiotti, M A Pantaleo, A Astolfi, et al.
ESMO Open
|
October 25, 2023
Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer
M Nannini, A Repaci, M C Nigro, et al.
ESMO Open
|
August 5, 2021
Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors: a retrospective, multicenter, real-world study
M Nannini, A Rizzo, M C Nigro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 27, 2023
Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib
C Serrano, S Bauer, D Gómez-Peregrina, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Clinical Sarcoma Research
|
January 13, 2017
Radiotherapy in the management of gist: state of the art and new potential scenarios
L Gatto, M Nannini, M Saponara, et al.
International Journal of Oncology
|
August 13, 2008
Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases
M A Pantaleo, M Nannini, E Lopci, et al.
Journal of Endocrinological Investigation
|
February 17, 2020
Radiologically defined lipid-poor adrenal adenomas: histopathological characteristics
A De Leo, C Mosconi, G Zavatta, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 12, 2018
Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments
S Tavolari, M Deserti, F Vasuri, et al.
Diseases of the Colon and Rectum
|
November 15, 2006
Impact of surgery on the development of duodenal cancer in patients with familial adenomatous polyposis
G Biasco, E Nobili, C Calabrese, et al.
Journal of Chemotherapy (Florence, Italy)
|
July 9, 2008
The role of cetuximab in pre-treated refractory patients with metastatic colorectal cancer: outcome study in clinical practice
G Lelli, S Cataldo, I Carandina, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 8, 2014
Activity of sunitinib in extraskeletal myxoid chondrosarcoma
S Stacchiotti, M A Pantaleo, A Astolfi, et al.
ESMO Open
|
October 25, 2023
Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer
M Nannini, A Repaci, M C Nigro, et al.
ESMO Open
|
August 5, 2021
Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors: a retrospective, multicenter, real-world study
M Nannini, A Rizzo, M C Nigro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 27, 2023
Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib
C Serrano, S Bauer, D Gómez-Peregrina, et al.
Page
of 4